Skip to main content
Clinical Trials/CTRI/2024/07/070428
CTRI/2024/07/070428Not yet recruitingPhase 4

A randomized open labelled comparative clinical study to evaluate the efficacy of oral administration of Maharasnadi Kashaya and Kapikacchu Choorna with Shuddha Bala Taila Matra Basti in the management of Kampavata with special reference to Parkinsons Disease.

Dr Prekshna Gabriella Paul1 site in 1 country30 target enrollmentStarted: July 20, 2024Last updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Significant decrease in symptoms of Parkinson’s Disease assessed based on MDS-UPDRS Scale.

Study Overview

Brief Summary

RESEARCH QUESTION

Whether oral administration of Maharasnadi kashaya along with Shuddha Bala taila

matra basti and Kapikachu choorna along with Shuddha Bala Taila Matra Basti is

effective in the management of Kampavata with special reference to Parkinson’s

Disease?

HYPOTHESIS

Null Hypothesis (H 0 ) = There is no significant difference between the two groups in

the clinical efficacy of Maharasnadi kashaya orally along with Shuddha Bala taila

matra basti and Kapikachu choorna orally along with Shuddha Bala taila matra basti

in the management of Kampavata with special reference to Parkinson’s Disease.

Alternative Hypothesis (H 1 ) = The clinical efficacy of Maharasnadi kashaya orally

along with Shuddha Bala taila matra basti is better than Kapikachu choorna orally

along with Shuddha Bala taila matra basti in Kampavata with special reference to

Parkinson’s Disease.

Alternative Hypothesis (H 2 ) : The clinical efficacy of Kapikachu choorna orally along

with Shuddha Bala Taila Matra Basti is better than Maharasnadi kashaya orally along

with Shuddha Bala taila matra basti in Kampavata with special reference to

Parkinson’s Disease.

6.4 AIM AND OBJECTIVES OF THE STUDY:

AIM: To clinically evaluate and compare the efficacy of Maharasnadi kashaya with

that of Kapikachu choorna along with Shuddha Bala taila matra basti in the

management of Kampavata with special reference to Parkinson’s Disease.

OBJECTIVES OF THE STUDY:

Primary objective:

● To clinically evaluate the efficacy of Maharasnadi kashaya with Shuddha Bala taila

matra basti in the management of Kampavata with Movement Disorder Society-

unified Parkinson’s Disease Rating Scale (MDS-UPDRS) in the clinical setting of the

institution.

● To clinically evaluate the efficacy of Kapikachu choorna with Shuddha Bala taila matra

basti in the management of Kampavata with MDS-UPDRS scale in the clinical setting

of the institution.

● To clinically compare and evaluate the efficacy of Maharasnadi kashaya and

Shuddha Bala taila matra basti with Kapikachu choorna and Shuddha Bala taila matra

basti in management of Kampavata with MDS-UPDRS scale in the clinical setting of

the institution.

Secondary objective:

● To undertake the detailed literary review of Kampavata with special reference to

Parkinson’s Disease.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
None

Eligibility Criteria

Ages
40.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Subjects presenting with the lakshanas of Kampavata like karapaadatale kampa(tremors), deha bhramana (whirling sensation), nidrabhanga(sleeplessness) and kshinamati (dementia).
  • Subjects presenting the clinical features of PD like tremors, rigidity, bradykinesia.
  • Subjects who have been freshly diagnosed with Idiopathic PD or less than 5 year history and those who are not on any medications for Parkinson’s disease.
  • Subjects irrespective of gender in between the age group 40 to 65 years.
  • Subjects who are indicated and fit for Matra basti.
  • Subjects willing to participate with written informed consent, which is conveyed in the language, which the subject can understand.

Exclusion Criteria

  • Subjects with other varieties of Tremors like essential tremors, senile tremors.
  • Subjects who are on any medications for Parkinson’s disease.
  • Subjects diagnosed with uncontrolled systemic diseases like HTN and DM.
  • Subjects with history of Major head injury.

Outcomes

Primary Outcomes

Significant decrease in symptoms of Parkinson’s Disease assessed based on MDS-UPDRS Scale.

Time Frame: Before intervention- 0th day | After intervention- 30th day | Follow up- 45th day

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Dr Prekshna Gabriella Paul
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Prekshna Gabriella Paul

Sri Sri College of Ayurvedic Science and research

Study Sites (1)

Loading locations...

Similar Trials